Abaxis, Inc. to Present at the Credit Suisse 26th Annual Healthcare Conference, the Canaccord Genuity Medical Technologies & Diagnostics Form 2017 and the Stifel 2017 Healthcare Conference
UNION CITY, Calif., Nov. 1, 2017 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, announced today that Ross Taylor, Chief Financial Officer, will present at the following investor conferences:
-- Credit Suisse 26(th) Annual Healthcare Conference on Tuesday, November
7, 2017 at 2:45 p.m. MT. The conference will be held at The Phoenician
in Scottsdale, Arizona.
-- Canaccord Genuity Medical Technologies & Diagnostics Forum 2017 on
Thursday, November 9, 2017 at 8:30 a.m. ET. The conference will be held
at The Westin New York Grand Central Hotel in New York City.
-- Stifel 2017 Healthcare Conference on Tuesday, November 14, 2017 at
8:00am ET. The conference will be held at the Lotte New York Palace
Hotel in New York City.
About Abaxis
Abaxis, Inc. is a worldwide developer, manufacturer and marketer of portable blood analysis systems that are used in a broad range of medical specialties in human or veterinary patient care to provide clinicians with rapid blood constituent measurements. Our mission is to improve the efficiency of care delivery to and the quality of life of patients in the medical and veterinary markets. We provide leading edge technology and tools that support best medical practices, enabling physicians and veterinarians to respond to the health needs of their clients at the point of care while operating economical and profitable practices. For more information, visit http://www.abaxis.com.
Contact: Clint Severson Lytham Partners, LLC
Chief Executive Officer Joe Dorame, Joe Diaz & Robert Blum
ABAXIS, Inc. 602-889-9700
510-675-6500
SOURCE Abaxis, Inc.
